Your search results are below. For a different search, enter another term below and click on the "Search" button:
-
501. FDA expands approval for Cologuard to 45-49 age range — 4 insights
The FDA expanded its approval for Exact Sciences' Cologuard to include the 45- to 49-year-old age range. What you should know: 1. The expansion comes at a time when early-onset colorectal cancer ...23 September 2019 -
502. 38 GI developments or transactions in 2019 so far
... Black hospitals and the Mary Black Physician group assets. Boston-based Dana-Farber/Brigham and Women's Cancer Center opened the Young-Onset Colorectal Cancer Center in response to elevated CRC rates ...17 September 2019 -
503. Early-onset CRC rates still on the rise in most countries — 5 insights
Early-onset colorectal cancer rates continue to increase globally, according to a study published in Gut. Researchers analyzed data from the Cancer Incidence in Five Continents dataset and other supplemental ...16 September 2019 -
504. Gastroenterology: An emerging trend in private equity healthcare transactions
... 101,420 new cases of colon cancer and 44,180 cases of rectal cancer expected in 2019. Further, this study showed that one in every 22 men as well as one in every 24 women will develop colorectal cancer.2 ...04 September 2019 -
505. What's the best CRC screening test? 'The one that gets completed,' says Dr. Aasma Shauk
Clinicians are discussing a myriad of ways to combat rising early-onset colorectal cancer rates, and while colonoscopy is the gold standard of diagnostic screening, the resource-heavy procedure could prove ...19 August 2019 -
506. June 2019 Issue of Becker's ASC Revie
... Medical Center dressed up as a red colon polyp named Paulie to educate staff and patients about colon cancer prevention in honor of colorectal cancer awareness month. 3 ASCs, endoscopy centers with the ...16 August 2019 -
507. 6 quotes from Exact Sciences CEO Kevin Conroy on the company, Cologuard & more
... to accelerate the availability of new innovative test to patients." On expanding Cologuard, the company's DNA-based colorectal cancer screening test, indications: "We recently submitted a label expansion ...31 July 2019 -
508. Exact Sciences increases Q2 revenues 94% — 5 insights
... another strong quarter, bringing us closer to our goal of capturing at least 40-percent share of the U.S. colorectal cancer screening market with Cologuard, from about 6 percent today. The foundation we've ...30 July 2019 -
509. AGA recognizes research efforts of 17 GI fellows
... in Patients With Inflammatory Bowel Disease" Shelly Gurwara, MD - Wake Forest Baptist Health Medical Center, Winston-Salem, N.C. "Optimizing Outpatient Colorectal Cancer Screening and Surveillance for ...26 July 2019 -
510. Simulation suggests blood, stool-based tests could boost CRC screening rates
A study published in American Health Drug Benefits suggested that blood and stool-based screening tests could prompt more people to get screened for colorectal cancer. Researchers created a model to ...26 July 2019 -
511. Liquid biopsy supply use increasing, despite concerns over early adoption — 3 insights
... are, and whether it applies to their patients." 3. Yet, despite fears over effectiveness, the tests hold plenty of promise. Concerning colorectal cancer, clinicians can use tests that detect circulating ...19 July 2019 -
512. Early-onset CRC rates continue to rise — 5 study insights
A study published in Cancer shows that early-onset colorectal cancer rates have continued to increase over the past decade. Researchers examined the National Cancer Database to explore the number of ...17 July 2019 -
513. CRC incidence rates increasing in younger population, despite steady screening
U.S colorectal cancer rates are increasing in populations under 55, despite colonoscopy screening rates remaining similar, according to an American Cancer Society analysis reported on by MedPage Today. ...16 July 2019 -
514. GI leader to know: Dr. David Lieberman of the Oregon Health & Science University
... Society for Gastrointestinal Endoscopy and served as an associate editor for Gastrointestinal Endoscopy. He is a chair of the CDC and American Cancer Society task force on colorectal cancer screening. ...15 July 2019 -
515. How patients felt about CRC care — 5 survey insights
Metastatic colorectal care patients offered insights into clinician care in a survey presented at the 2019 World Congress on Gastrointestinal Cancer, July 3-6 in Barcelona, Spain, Medscape reports. Researchers ...12 July 2019 -
516. 5 biggest GI trends in 2019 — Private equity, salaries, cancer rates & more
As the dog days of summer inch ever closer, here are some of the biggest stories and trends that have defined gastroenterology through the first half 2019. Rising worldwide colorectal cancer mortality ...11 July 2019 -
517. Blood-based CRC test maker receives recognition — 3 insights
... excelling in their respective fields. 2. Epigenomics received the award for its noninvasive blood-based cancer diagnostic tests. 3. One such test, Epi proColon, is a blood-based colorectal cancer test. ...11 July 2019 -
518. AI in gastroenterology: 4 Qs with Dr. Mark Lambrecht of SAS
... or an adenoma. Colorectal cancer is the third most common cancer worldwide, and in about half of patients, the cancer spreads to the liver. SAS is partnered with Amsterdam University Medical Center in ...10 July 2019 -
519. Exact Sciences opens new laboratory, can process up to 7M tests — 3 insights
... tests by the end of 2019. Cologuard is a noninvasive screening test for colorectal cancer. 2. The newly opened lab can process 4 million tests, while Exact's existing lab can process 3 million tests. ...27 June 2019 -
520. May/June Issue of Becker's ASC Revie
... the gold standard in US, despite alternatives — 7 insights Medscape reviewed current colorectal cancer screening tests options as well as research surrounding them to quantify which is the most effective. ...25 June 2019